WuXi STA, a subsidiary of WuXi AppTec, is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry, with global operations. As a premier Contract Development and Manufacturing Organization (CDMO), WuXi STA offers our worldwide partners efficient, flexible and high-quality solutions for integrated CMC (Chemical, Manufacturing, and Control) from preclinical to commercial.
WuXi STA peptide platform provides comprehensive CRDMO services from drug discovery to commercial manufacturing, combining traditional CRO (Contract Research Organization), CDMO (Contract Development and Manufacturing Organization) and CMO (Contract Manufacturing Organization) services under one roof.
Our vertically integrated peptide platform covers from unnatural amino acid, conjugate, API to drug product, coupled with comprehensive analytical support and CMC writing service, supporting our customers bring their peptide therapeutics to market faster.
Our Vision
Transform how industry develops and manufactures medicines, shorten the time and lower the cost of new drug developments, fulfill the dream that every drug can be made and every disease can be treated.
Our Mission
Become your trusted global partner for pharmaceutical development and manufacturing from preclinical to commercial.
